Garenoxacin mesylate hydrate
CAS: 223652-90-2
Ref. 3D-FG40128
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Información del producto
- 1-Cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid methanesulfonate hydrate
- 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate hydrate (1:1:1)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, methanesulfonate, hydrate (1:1:1)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-2,3-dihydro-1-methyl-1H-isoindol-5-yl]-1,4-dihydro-4-oxo-, monomethanesulfonate, monohydrate
- Geninax
Garenoxacin mesylate hydrate is a quinolone antibiotic that suppresses the growth of bacteria by inhibiting DNA-dependent RNA polymerase in prokaryotes. It has been shown to be active against a wide range of bacterial strains. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death.
Propiedades químicas
Consulta técnica sobre: 3D-FG40128 Garenoxacin mesylate hydrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
